カテゴリ： GlobalData, ベルギー, 企業調査

Biocartis Group NV (BCART) – Product Pipeline Analysis, 2018 Uate

◆英語タイトル：Biocartis Group NV (BCART) - Product Pipeline Analysis, 2018 Uate
◆商品コード：DATA904C12533
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：59
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ベルギー
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Biocartis Group NV (Biocartis) is a molecular diagnostics company that provides personalized medicine for patients through its molecular diagnostics. The company undertakes the development of diagnostics technology platforms for multiplexed detection of bio-analytes, with oncology as its key focus area. Its Idylla is a molecular diagnostics system that provides easy access to clinical molecular diagnostic information. Biocartis also offers a wide range of oncology assays such as Idylla BRAF Mutation Test, Idylla KRAS Mutation Test, Idylla EGFR Mutation Test and Idylla NRAS Mutation. The company has operations in Belgium and Switzerland. Biocartis is headquartered in Mechelen, Belgium.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biocartis Group NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Biocartis Group NV Company Overview 6
Biocartis Group NV Company Snapshot 6
Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview 6
Biocartis Group NV – Pipeline Analysis Overview 9
Biocartis Group NV – Key Facts 9
Biocartis Group NV – Major Products and Services 10
Biocartis Group NV Pipeline Products by Development Stage 11
Biocartis Group NV Pipeline Products Overview 14
EGFR Colon Cancer Test 14
EGFR Colon Cancer Test Product Overview 14
Idylla Blood Stream Infections Panel 15
Idylla Blood Stream Infections Panel Product Overview 15
Idylla ctEGFR Assay 16
Idylla ctEGFR Assay Product Overview 16
Idylla Extended KRAS Mutation Test 17
Idylla Extended KRAS Mutation Test Product Overview 17
Idylla Extended NRAS Mutation Test 18
Idylla Extended NRAS Mutation Test Product Overview 18
Idylla HPV Test – Head & Neck Cancer 19
Idylla HPV Test – Head & Neck Cancer Product Overview 19
Idylla Immuno Tx Panel Test 20
Idylla Immuno Tx Panel Test Product Overview 20
Idylla KRAS Mutation Test 21
Idylla KRAS Mutation Test Product Overview 21
Idylla Liquid Biopsy EGFR Mutation Assay 22
Idylla Liquid Biopsy EGFR Mutation Assay Product Overview 22
Idylla Liquid Biopsy Test – Breast Cancer 23
Idylla Liquid Biopsy Test – Breast Cancer Product Overview 23
Idylla Meningitis Assay 24
Idylla Meningitis Assay Product Overview 24
Idylla MERS Assay 25
Idylla MERS Assay Product Overview 25
Idylla MSI Test 26
Idylla MSI Test Product Overview 26
Idylla Multiplex Respiratory Panel 27
Idylla Multiplex Respiratory Panel Product Overview 27
Idylla Neuro Panel Test 28
Idylla Neuro Panel Test Product Overview 28
Idylla Neurological Disease Assay 29
Idylla Neurological Disease Assay Product Overview 29
Idylla NGS Prep Panel – Pan-Tumor 30
Idylla NGS Prep Panel – Pan-Tumor Product Overview 30
Idylla NRAS Mutation Test 31
Idylla NRAS Mutation Test Product Overview 31
Idylla NRAS-BRAF Mutation Test 32
Idylla NRAS-BRAF Mutation Test Product Overview 32
Idylla Retrieve – NGS Hotspot Panel Assay 33
Idylla Retrieve – NGS Hotspot Panel Assay Product Overview 33
Idylla Sepsis Assay 34
Idylla Sepsis Assay Product Overview 34
Idylla Solid Biopsy Test – Breast Cancer 35
Idylla Solid Biopsy Test – Breast Cancer Product Overview 35
Idylla Syndromic Immunocompromised Panel 36
Idylla Syndromic Immunocompromised Panel Product Overview 36
Idylla Syndromic Panel – Tropical Fever 37
Idylla Syndromic Panel – Tropical Fever Product Overview 37
Idylla System – Multiplex Companion Diagnostics Test 38
Idylla System – Multiplex Companion Diagnostics Test Product Overview 38
Idylla Viral Load Assay – HBV 39
Idylla Viral Load Assay – HBV Product Overview 39
Idylla Viral Load Assay – HCV 40
Idylla Viral Load Assay – HCV Product Overview 40
Idylla Viral Load Assay – HIV 41
Idylla Viral Load Assay – HIV Product Overview 41
SeptiCyte Triage 42
SeptiCyte Triage Product Overview 42
Biocartis Group NV – Key Competitors 43
Biocartis Group NV – Key Employees 44
Biocartis Group NV – Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Recent Developments 46
Biocartis Group NV, Recent Developments 46
Jul 17, 2018: Biocartis launches innovative Idylla MSI Assay 46
Jun 27, 2018: Study Reviewing 2,500 Performed Idylla Tests Shows Generation of Valid Results in 98.1% of Cases 46
May 28, 2018: Study Demonstrates Ability of Idylla EGFR Mutation Test to Produce a Result in 80% of Failed Next Generation Sequencing Lung Cancer Tests 47
May 17, 2018: Biocartis Group: Two Performance Studies on Idylla MSI Biomarkers Selected for Publication at ASCO Conference 47
Apr 26, 2018: Biocartis Q1 2018 Business Update 48
Mar 15, 2018: Biocartis Abstract on Performance Idylla ctRAS Liquid Biopsy Tests Selected for Oral Presentation at 2018 American Association for Cancer Research Meeting 50
Mar 01, 2018: Biocartis Announces 2017 Results and 2018 Outlook 50
Mar 01, 2018: Biocartis Establishes R&D Center in the US 53
Mar 01, 2018: European Union provides Biocartis with up to EUR 24m debt financing facility for infectious disease projects 54
Feb 26, 2018: EPD Obtains European Regulatory Approval for Its Cardiac Mapping and Navigation System 55
Appendix 56
Methodology 56
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Biocartis Group NV Pipeline Products and Ongoing Clinical Trials Overview 6
Biocartis Group NV Pipeline Products by Equipment Type 7
Biocartis Group NV Pipeline Products by Indication 8
Biocartis Group NV, Key Facts 9
Biocartis Group NV, Major Products and Services 10
Biocartis Group NV Number of Pipeline Products by Development Stage 11
Biocartis Group NV Pipeline Products Summary by Development Stage 12
EGFR Colon Cancer Test - Product Status 14
EGFR Colon Cancer Test - Product Description 14
Idylla Blood Stream Infections Panel - Product Status 15
Idylla Blood Stream Infections Panel - Product Description 15
Idylla ctEGFR Assay - Product Status 16
Idylla ctEGFR Assay - Product Description 16
Idylla Extended KRAS Mutation Test - Product Status 17
Idylla Extended KRAS Mutation Test - Product Description 17
Idylla Extended NRAS Mutation Test - Product Status 18
Idylla Extended NRAS Mutation Test - Product Description 18
Idylla HPV Test - Head & Neck Cancer - Product Status 19
Idylla HPV Test - Head & Neck Cancer - Product Description 19
Idylla Immuno Tx Panel Test - Product Status 20
Idylla Immuno Tx Panel Test - Product Description 20
Idylla KRAS Mutation Test - Product Status 21
Idylla KRAS Mutation Test - Product Description 21
Idylla Liquid Biopsy EGFR Mutation Assay - Product Status 22
Idylla Liquid Biopsy EGFR Mutation Assay - Product Description 22
Idylla Liquid Biopsy Test - Breast Cancer - Product Status 23
Idylla Liquid Biopsy Test - Breast Cancer - Product Description 23
Idylla Meningitis Assay - Product Status 24
Idylla Meningitis Assay - Product Description 24
Idylla MERS Assay - Product Status 25
Idylla MERS Assay - Product Description 25
Idylla MSI Test - Product Status 26
Idylla MSI Test - Product Description 26
Idylla Multiplex Respiratory Panel - Product Status 27
Idylla Multiplex Respiratory Panel - Product Description 27
Idylla Neuro Panel Test - Product Status 28
Idylla Neuro Panel Test - Product Description 28
Idylla Neurological Disease Assay - Product Status 29
Idylla Neurological Disease Assay - Product Description 29
Idylla NGS Prep Panel - Pan-Tumor - Product Status 30
Idylla NGS Prep Panel - Pan-Tumor - Product Description 30
Idylla NRAS Mutation Test - Product Status 31
Idylla NRAS Mutation Test - Product Description 31
Idylla NRAS-BRAF Mutation Test - Product Status 32
Idylla NRAS-BRAF Mutation Test - Product Description 32
Idylla Retrieve - NGS Hotspot Panel Assay - Product Status 33
Idylla Retrieve - NGS Hotspot Panel Assay - Product Description 33
Idylla Sepsis Assay - Product Status 34
Idylla Sepsis Assay - Product Description 34
Idylla Solid Biopsy Test - Breast Cancer - Product Status 35
Idylla Solid Biopsy Test - Breast Cancer - Product Description 35
Idylla Syndromic Immunocompromised Panel - Product Status 36
Idylla Syndromic Immunocompromised Panel - Product Description 36
Idylla Syndromic Panel - Tropical Fever - Product Status 37
Idylla Syndromic Panel - Tropical Fever - Product Description 37
Idylla System - Multiplex Companion Diagnostics Test - Product Status 38
Idylla System - Multiplex Companion Diagnostics Test - Product Description 38
Idylla Viral Load Assay - HBV - Product Status 39
Idylla Viral Load Assay - HBV - Product Description 39
Idylla Viral Load Assay - HCV - Product Status 40
Idylla Viral Load Assay - HCV - Product Description 40
Idylla Viral Load Assay - HIV - Product Status 41
Idylla Viral Load Assay - HIV - Product Description 41
SeptiCyte Triage - Product Status 42
SeptiCyte Triage - Product Description 42
Biocartis Group NV, Key Employees 44
Biocartis Group NV, Subsidiaries 45
Glossary 58

List of Figures
Biocartis Group NV Pipeline Products by Equipment Type 7
Biocartis Group NV Pipeline Products by Development Stage 11

★海外企業調査レポート[Biocartis Group NV (BCART) – Product Pipeline Analysis, 2018 Uate]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • G. Pohl-Boskamp GmbH & Co KG：製薬・医療：M&Aディール及び事業提携情報
    Summary G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual …
  • Landmark Graphics Corp：企業の戦略的SWOT分析
    Landmark Graphics Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bon Secours Health System Inc：企業の戦略的SWOT分析
    Bon Secours Health System Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Trethera Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary Trethera Corp (Trethera), formerly Triangle Therapeutics Inc is a clinical-stage biopharmaceutical company that discovers and develops novel therapies and treatment strategies in oncology. The corporation’s lead program combines TRE-515, a novel deoxycytidine kinase inhibitor with Triapine, …
  • Greer Laboratories Inc-製薬・医療分野：企業M&A・提携分析
    Summary Greer Laboratories Inc (Greer), a subsidiary of Stallergenes Greer plc, is a pharmaceutical company that provides allergy immunotherapy products and services to the healthcare industry. The company provides products in the area of human allergy, veterinary allergy and source materials. It of …
  • Zuger Kantonalbank AG：企業の戦略・SWOT・財務分析
    Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Zuger Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • KENKO Mayonnaise Co Ltd：企業の戦略・SWOT・財務分析
    KENKO Mayonnaise Co Ltd - Strategy, SWOT and Corporate Finance Report Summary KENKO Mayonnaise Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hayashibara Co Ltd：企業の戦略的SWOT分析
    Hayashibara Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Psychemedics Corp (PMD)：企業の財務・戦略的SWOT分析
    Summary Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzod …
  • First Abu Dhabi Bank PJSC (FAB)：企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank PJSC (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Isrotel Hotels Management Inc.：企業の戦略・SWOT・財務分析
    Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report Summary Isrotel Hotels Management Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • PAL Holdings, Inc.：企業の戦略・SWOT・財務情報
    PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nitori Holdings Co Ltd：企業の戦略・SWOT・財務分析
    Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nitori Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genentech Inc-医療機器分野：企業M&A・提携分析
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that develops and markets medicines to address serious medical needs. Its clinical development pipeline includes alectinib and Erlotinib for metastatic non-small cell lung cancer; Anti-ST2 for ast …
  • Insmed Inc (INSM)：医療機器：M&Aディール及び事業提携情報
    Summary Insmed Inc (Insmed) is a biopharmaceutical company that focuses on rare diseases. Its lead product candidate, Arikayce (liposomal amikacin for inhalation), is indicated for the treatment of nontuberculous mycobacteria (NTM) lung disease in adult patients. Its other clinical pipeline are bein …
  • Pyng Medical Corp：医療機器：M&Aディール及び事業提携情報
    Summary Pyng Medical Corp (Pyng Medical), a subsidiary of Teleflex Medical Canada Inc, is a medical device company that manufactures and markets trauma and resuscitation products. The company offers products such as fast1 intraosseous infusion system, fastresponder sternal intraosseous device, mat t …
  • Amec Foster Wheeler plc (formerly AMEC plc)：戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Terumo BCT Inc-製薬・医療分野：企業M&A・提携分析
    Summary Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood component, therapeutic apheresis, and cellular technologies. The company’s product portfolio include automated blood collection system, information system, data collection system, apheresis system, cell processor, cell …
  • IQVIA Holdings Inc (IQV)：企業の財務・戦略的SWOT分析
    IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Servest Group Ltd：企業の戦略的SWOT分析
    Servest Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆